Abstract Presentations
Oral Abstract Presentations
On-Demand Access 24/7
3.5 AMA PRA Category 1 CreditTM
These presentations will have a mix of case reports, clinical studies and basic science presentations. Resident and fellow-in-training oral abstract presenters are eligible for the ASDP Physician-in-Training Awards. Award recipients will be announced online after the annual meeting. Oral abstract presenters listed below will participate in the Oral and Poster Defense 1 on Monday, November 9 between 11:00 a.m. - Noon Central.
| Speaker |
Title |
| |
|
Phyu P. Aung, MD, PhD
|
Standardized Method for Defining a 1-mm2 Region of Interest for Calculation of Mitotic Rate on Melanoma Whole Slide Images |
| |
|
| Sara Behbahani, MS |
Malignant Cutaneous Adnexal Tumors of the Eyelid |
| |
|
| John Bosland, BS |
Perifollicular Microscarring in Alopecia Areata |
| |
|
Alina G. Bridges, DO
|
A Combined Clinicopathologic and Gene Expression Model (Merlin Assay) to Risk Stratify Cutaneous Melanoma Patients in Clinical Practice: A Pilot Study |
| |
|
Katrina M. Collins, MD
|
Is GATA3 Helpful in the Diagnosis of Transformed Mycosis Fungoides Versus Cutaneous CD30+ T Cell Lymphoproliferative Disorders? A Study of 48 Cases |
| |
|
Luke T. Dang, MD, PhD
|
PRAME Immunohistochemistry: Its Role in Diagnosis, Diagnostic Confidence and Recommended Clinical Management in Challenging Melanocytic Neoplasms |
| |
|
| Mona Deerwester, MD, MS |
GLUT1 as a Diagnostic Marker for Syringoma and Microcystic Adnexal Carcinoma |
| |
|
| Pedram Gerami, MD |
Clinical, Morphologic and Genomic Findings in ROS1 Fusion Spitz Neoplasms |
| |
|
| Paul B. Googe, MD |
PRAME Immunostaining in a Series of Melanocytic Neoplasms |
| |
|
| Yuan Yu Huang, MD |
Spitz Melanoma with a Novel BRAF-MYO5A Kinase Fusion: A Case Report |
| |
|
Samira Mortazavi, MD
|
Role of Nestin and SOX2 Expression in Differentiating Melanocytic Nevus from Primary Malignant Melanoma |
| |
|
Kiran Motaparthi, MD
|
Clinically Meaningful Classification of Melanocytic Tumors by a Deep Learning Algorithm |
| |
|
Neil M. Neuman, MD, PhD
|
Breast Hidradenoma and Breast Mucoepidermoid Carcinoma Share Pathologic Features and Molecular Alteration |
| |
|
Michael Occidental, MD
|
Comparative Epigenetic Analysis of Merkel Cell Carcinoma in Association with Chronic Lymphocytic Leukemia |
| |
|
Mason Runge, MD
|
Molecular Profiling of Squamoid Eccrine Ductal Carcinoma Suggests Similarity to Squamous Cell Carcinoma |
| |
|
| Anurag Sharma, MD |
A Clinicopathologic Analysis of a Series of 54 Cases of Superficial Angiomyxoma |
| |
|
| Olayemi Sokumbi, MD |
The Evolution of Dupilumab-associated Cutaneous Atypical Lymphoid Infiltrates |
| |
|
Andrew W. Tharp, MD
|
The Clinical Utility of PRAME Immunohistochemistry in the Classification of Challenging Melanocytic Tumors |
| |
|
Zachariah Thomas, MBBS
|
Identification of a Novel Large Deletion in EVER1 Gene in Epidermodysplasia Verruciformis – The First Report from India |
| |
|
| Bicong Wu, MD |
Utility of Abdominal Skin Punch Biopsy for Detecting Systemic Amyloidosis |
Learning Objectives
Upon completion of these sessions, participants should be able to:
- Identify various clinical and basic science topics within dermatopathology.
- Exemplify and promote exchange of new ideas and concepts within the field of dermatopathology.
- Describe innovative investigative studies and tools pertaining to bench and translational research.
- Compare unique pathological perspectives and concepts as they relate to individual and groups of cases.
Poster Presentations
On-Demand Access 24/7
2 AMA PRA Category 1 CreditTM
Participants will earn 1 AMA PRA Category 1 Credit™ for each Oral & Poster Abstract Defense Session attended.
Basic research, practical techniques and new clinical or histopathologic entities will be presented in this traditional and popular format. Posters will be on display in two poster sessions. Residents and fellows-in-training are eligible for the ASDP Physician-in-Training Awards. Award recipients will be notified by email after the meeting.
Defense Sessions
The defense sessions will provide an opportunity for discussion between oral and poster presenters and attendees. Presenters are asked to make every effort to attend the defense sessions.
Oral and Poster Abstract Defense 1:
Monday, November 9
11:00 a.m. – Noon
Oral and Poster Abstract Defense 2:
Tuesday, November 10
11:30 a.m. – 12:30 p.m.
Learning Objectives
After attending the Oral and Poster Defense Sessions, participants should be able to:
- Identify practical techniques in dermatopathology.
- Name new clinical or histopathological entities.